AROA Biosurgery Limited
Clinical trials sponsored by AROA Biosurgery Limited, explained in plain language.
A medical device company developing surgical and wound-care products from biological materials.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Sheep membrane may help cover exposed bone faster Results expected Mar 2027 (estimated)
-
New dressing aims to heal stubborn diabetic foot sores
Disease control CompletedThis study tested a special wound dressing called Symphony™ against standard care for people with diabetic foot ulcers that won't heal. 143 adults with mild to moderate ulcers took part. The goal was to see if Symphony™ helps more ulcers close completely within 12 weeks and how q…
Sponsor: Aroa Biosurgery Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New dressing combo shows promise for stubborn diabetic foot sores
Disease control CompletedThis pilot study tested a staged application of two wound dressings (Endoform and Symphony) on 44 adults with chronic diabetic foot ulcers. The goal was to see if the treatment could fully close the wound within 12 weeks. Researchers measured healing rates, wound size reduction, …
Sponsor: Aroa Biosurgery Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC